Breaking Big? Rethinking Big Pharma’s Blockbuster Model


Mar 06, 2013

The Motley Fool

“Prepare for the end of the blockbuster world big pharma …” If one didn’t know better that might be the tome on some crazy guy’s sandwich board walking down Wall Street these days. The end of the blockbuster model may be nearer than we think: The Motley Fool analysts Keith Spieghts and Brian Orelli offer keen insight into how market forces and other competitive pressures are pushing the pharmaceutical industry in new strategic directions. Fortunately they also offer a glimpse of where blockbusters can still do well in the changing pharma universe. Read more here.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments